Abbott LaboratoriesABT:NYQ

1.53 / 3.70 %
5.90 %
Latest price in USDToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Oct 06 2015 20:59 BST.


On Tuesday, Abbott Laboratories (ABT:NYQ) closed at 39.86, 2.21% above its 52-week low of 39.00, set on Sep 28, 2015.

52-week range
Sep 28 2015
Jul 23 2015
Markit short selling activity
Day high41.34
Day low39.28
Previous close41.39
Average volume9.63m
Shares outstanding1.49bn
Free float1.49bn
P/E (TTM)26.26
Market cap61.69bn USD
Annual div (IAD)0.96 USD
Annual div yield (IAD)2.32%
Div ex-dateJul 13 2015
Div pay-dateAug 15 2015
Next div ex-dateOct 13 2015
Next div pay-dateNov 15 2015
Data delayed at least 15 minutes, as of Oct 06 2015 20:59 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Abbott Laboratories+0.91 %-7.45 %-13.70 %-5.90 %+57.24 %
S&P 500 INDEX+5.46 %+3.43 %-4.30 %+1.13 %+71.30 %
USA/HEALTH CARE+5.25 %-0.54 %-5.63 %+6.73 %+55.93 %
USA/H CARE EQUIP&SUPPL+4.52 %-0.36 %-7.03 %+5.98 %+46.78 %
Data delayed at least 15 minutes, as of Oct 06 2015 20:59 BST.
© Thomson Reuters Click for restrictions.

All markets data located on is subject to the FT Terms & Conditions.

All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.